Precise Investors

Friday, August 12, 2022
Stocks & Shares

Shares in Asia-Pacific mixed as Chinese tech shares slip

index fell

Hang Seng index fell 0.19%, Nikkei 225 gained 0.27%, Shanghai composite gained 0.41%, Shenzhen component was down 0.06% and Kospi gained 0.21%

Shares in Asia-Pacific were mixed on Friday, as Chinese tech shares slipped and investors watched the Covid situation in China.

Hong Kong’s Hang Seng index fell 0.19%, while the Hang Seng Tech index dropped 1.93%. Alibaba slid 2.38%, while shed 3.17%. Meituan lost 2.95%.

Mainland Chinese markets were mixed. The Shanghai composite gained 0.41%, while the Shenzhen component was down 0.06%.

Covid is in focus in China, with Shanghai reporting 20,398 new asymptomatic coronavirus cases and 824 new symptomatic cases on April 7.

Near-term sentiment (for Chinese shares) could stay curbed given a confluence of macro headwinds, Omicron spread, global liquidity uncertainty and US/China tension concerns, according to a Morgan Stanley note dated April 7.

The bank’s analysts also noted that domestic consumption in China is sluggish, and said the sporadic spread of the virus beyond Shanghai could lead to tightening measures in other places.

Japan’s Nikkei 225 gained 0.27%, while the Topix inched up 0.09%. Both indexes struggled for direction. In South Korea, the Kospi gained 0.21%, and the Kosdaq gained 0.7%. Australia’s S&P/ASX 200 rose 0.50%.

The biggest headwind for Asia markets currently comes from the U.S., where markets are responding to hawkish signals from the Fed, said Julia Wang, a global market strategist at JPMorgan Private Bank.

Major stock indexes in the U.S. reversed losses to rise slightly at the close.

The Dow Jones Industrial Average gained 87.06 points, or 0.25%, to 34,583.57 after losing as much as 300 points earlier in the session. The S&P 500 was up 0.43% at 4,500.21, and the Nasdaq Composite inched up 0.06% to 13,897.30 following two straight days of losses.

Defensive stocks such as consumer staples and health care led the market comeback.


The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.

Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.

There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.

Leave a Reply